Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01713829 · ClinicalTrials.gov registry record · NA
Cranberry Consumption Improves γδ T Cell Function
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT01713829 is a NA study that has completed, run by University of Florida. The registered enrollment target is 52 participants.
The verdict
NCT01713829, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the extent to which consuming a cranberry beverage modifies immune function, specifically related to γδ T cells and other innate immune cells. It is hypothesized that cranberry components will interact with immune cells to activate signaling pathways that enhance cell function. Enhanced immune cell function should result in reduced number, duration, and severity of cold and flu symptoms.
Interventions
- OTHER Cranberry Beverage
- OTHER Placebo Beverage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2012-10 |
| Est. Completion | 2013-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01713829
The ClinicalTrials.gov registry entry for NCT01713829 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cranberry Beverage is the first listed.
NCT01713829 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01713829 about?
NCT01713829 is a clinical study titled "Cranberry Consumption Improves γδ T Cell Function". The purpose of this study is to determine the extent to which consuming a cranberry beverage modifies immune function, specifically related to γδ T cells and other innate immune cells. It is hypothesized that cranberry components will interact with immune cells to activate signaling pathways that en...
What is the current status of trial NCT01713829?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2012-10. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01713829?
The interventions under investigation include: Cranberry Beverage (OTHER), Placebo Beverage (OTHER).
Who is sponsoring clinical trial NCT01713829?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.